134 related articles for article (PubMed ID: 2415279)
21. Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.
Baron GC; Klimas NG; Fischl MA; Fletcher MA
Diagn Immunol; 1985; 3(4):197-204. PubMed ID: 3866646
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells.
Allavena P; Klein R; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):7-20. PubMed ID: 3875792
[TBL] [Abstract][Full Text] [Related]
23. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin.
Sirianni MC; Soddu S; Malorni W; Arancia G; Aiuti F
J Immunol; 1988 Apr; 140(8):2565-8. PubMed ID: 3356900
[TBL] [Abstract][Full Text] [Related]
25. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
26. Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.
Introna M; Allavena P; Biondi A; Colombo N; Villa A; Mantovani A
J Natl Cancer Inst; 1983 Jan; 70(1):21-6. PubMed ID: 6337291
[TBL] [Abstract][Full Text] [Related]
27. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
Reddy MM; Chinoy P; Grieco MH
J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880
[TBL] [Abstract][Full Text] [Related]
29. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
30. [Natural killer (NK) activity in patients with HIV infection].
Ortona L; Tamburrini E; Tumbarello M; Ventura G; Cauda R
Boll Ist Sieroter Milan; 1988; 67(2):135-41. PubMed ID: 3228497
[TBL] [Abstract][Full Text] [Related]
31. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
32. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
Mandler RN; Biddison WE; Mandler R; Serrate SA
J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
34. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
35. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
36. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
37. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
38. Impaired natural killing activity in patients with rheumatoid arthritis. Clinical characteristics and a study of defective mechanisms.
Fantini F; Valenti F; Mercuriali F; Marin F; Panajotopoulos N
Boll Ist Sieroter Milan; 1986; 65(1):40-6. PubMed ID: 3487336
[TBL] [Abstract][Full Text] [Related]
39. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
40. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
